These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25010949)

  • 61. Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis.
    Hirst JA; Farmer AJ; Dyar A; Lung TW; Stevens RJ
    Diabetologia; 2013 May; 56(5):973-84. PubMed ID: 23494446
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Assessing potential glycemic overtreatment in persons at hypoglycemic risk.
    Tseng CL; Soroka O; Maney M; Aron DC; Pogach LM
    JAMA Intern Med; 2014 Feb; 174(2):259-68. PubMed ID: 24322626
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and tolerability of linagliptin added to a sulfonylurea regimen in patients with inadequately controlled type 2 diabetes mellitus: an 18-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Lewin AJ; Arvay L; Liu D; Patel S; von Eynatten M; Woerle HJ
    Clin Ther; 2012 Sep; 34(9):1909-19.e15. PubMed ID: 22939034
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA).
    Christensen AS; Hædersdal S; Støy J; Storgaard H; Kampmann U; Forman JL; Seghieri M; Holst JJ; Hansen T; Knop FK; Vilsbøll T
    Diabetes Care; 2020 Sep; 43(9):2025-2033. PubMed ID: 32661107
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inadvertent sulfonylurea overdosage and hypoglycemia in an elderly woman: failure of serum hypoglycemia screening.
    Earle KE; Rushakoff RJ; Goldfine ID
    Diabetes Technol Ther; 2003; 5(3):449-51. PubMed ID: 12828829
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessing hypoglycemia frequency using flash glucose monitoring in older Japanese patients with type 2 diabetes receiving oral hypoglycemic agents.
    Abe H; Shikuma J; Suwanai H; Sano K; Okumura T; Kan K; Takahashi T; Miwa T; Suzuki R; Odawara M
    Geriatr Gerontol Int; 2019 Oct; 19(10):1030-1035. PubMed ID: 31486247
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial.
    Cahn A; Raz I; Mosenzon O; Leibowitz G; Yanuv I; Rozenberg A; Iqbal N; Hirshberg B; Sjostrand M; Stahre C; Im K; Kanevsky E; Scirica BM; Bhatt DL; Braunwald E
    Diabetes Care; 2016 Aug; 39(8):1329-37. PubMed ID: 27222508
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trials.
    Lajara R; Aguilar R; Hehnke U; Woerle HJ; von Eynatten M
    Clin Ther; 2014 Nov; 36(11):1595-605. PubMed ID: 25236917
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Will DPP-4 inhibitors replace sulfonylureas in the treatment of type 2 diabetes? Contra].
    Müller UA
    Dtsch Med Wochenschr; 2011 Mar; 136(11):547. PubMed ID: 21351042
    [No Abstract]   [Full Text] [Related]  

  • 70. Glycemic control paradox: Poor glycemic control associated with higher one-year and eight-year risks of all-cause hospitalization but lower one-year risk of hypoglycemia in patients with type 2 diabetes.
    Li TC; Kardia SL; Li CI; Chen CC; Liu CS; Yang SY; Muo CS; Peyser PA; Lin CC
    Metabolism; 2015 Sep; 64(9):1013-21. PubMed ID: 26026367
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
    Lipska KJ; Parker MM; Moffet HH; Huang ES; Karter AJ
    JAMA; 2018 Jul; 320(1):53-62. PubMed ID: 29936529
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Octreotide for sulfonylurea-induced hypoglycemia following overdose.
    Carr R; Zed PJ
    Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Attitude and safety of patients with diabetes observing the Ramadan fast.
    Ba-Essa EM; Hassanein M; Abdulrhman S; Alkhalifa M; Alsafar Z
    Diabetes Res Clin Pract; 2019 Jun; 152():177-182. PubMed ID: 30946851
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypoglycemia Incidence Rates and Associated Health Care Costs in Patients with Type 2 Diabetes Mellitus Treated with Second-Line Linagliptin or Sulfonylurea After Metformin Monotherapy.
    Raju A; Shetty S; Cai B; D'Souza AO
    J Manag Care Spec Pharm; 2016 May; 22(5):483-92. PubMed ID: 27123911
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.
    Dills DG; Schneider J
    Horm Metab Res; 1996 Sep; 28(9):426-9. PubMed ID: 8911977
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.
    Jermendy G; ; Erdesz D; Nagy L; Yin D; Phatak H; Karve S; Engel S; Balkrishnan R
    Health Qual Life Outcomes; 2008 Oct; 6():88. PubMed ID: 18976457
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacogenetics of sulfonylurea-induced hypoglycemia in Type 2 diabetes patients: the SUCLINGEN study.
    Loganadan NK; Huri HZ; Vethakkan SR; Hussein Z
    Pharmacogenomics; 2021 Nov; 22(16):1057-1068. PubMed ID: 34665019
    [No Abstract]   [Full Text] [Related]  

  • 78. Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study.
    Wong CKH; Man KKC; Shi M; Chan EW; Ho CW; Tse ETY; Wong ICK; Lam CLK
    PLoS Med; 2019 Dec; 16(12):e1002999. PubMed ID: 31877127
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacogenetics of hypoglycemia associated with sulfonylurea therapy in usual clinical care.
    Mitchell SL; Leon DAC; Chaugai S; Kawai VK; Levinson RT; Wei WQ; Stein CM
    Pharmacogenomics J; 2020 Dec; 20(6):831-839. PubMed ID: 32504053
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Incidence rate and patient characteristics of severe hypoglycemia in treated type 2 diabetes mellitus patients in Japan: Retrospective Diagnosis Procedure Combination database analysis.
    Ikeda Y; Kubo T; Oda E; Abe M; Tokita S
    J Diabetes Investig; 2018 Jul; 9(4):925-936. PubMed ID: 29171937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.